AstraZeneca
AstraZeneca has a deep-rooted heritage in the Oncology therapeutic area. Our vision is to help patients by redefining the cancer treatment paradigm and one day eliminate cancer as a cause of death. Our broad pipeline of next-generation medicines is focused on four main disease areas - ovarian, lung, breast and haematological cancers. These are being targeted through four key platforms – immuno-oncology, genetic drivers of cancer and resistance, DNA damage repair and antibody drug conjugates.